CD28 and malignant colon neoplasm: For this purpose, T cells from tdLN of BALB/c mice bearing subcutaneous CT26 colon cancer tumors were isolated and stimulated ex vivo with CD3/CD28 activation beads to generate a polyclonal population of CT26 tumor antigen–reactive T cells (Fig. 5A).